logo
Plus   Neg
Share
Email

PZ Cussons Proposes To Sell Nutricima, Completes Luksja Sale

Consumer products group PZ Cussons Plc. (PZC.L) said Wednesday it proposes to sell its Nigerian dairy business Nutricima, as part of its Focus, Scale and Accelerate strategy. The Group also said it completed sale of its Polish personal care brand Luksja.

PZ Cussons said it is selling its assets associated with Nutricima's business to FrieslandCampina WAMCO Nigeria Plc, an affiliate of Royal FrieslandCampina in the Netherlands. The deal is subject to merger clearance in Nigeria.

The Group said it sold its Polish personal care brand to Athens based personal care company, Sarantis Group. Sarantis will also distribute certain PZ Cussons' brands in Poland and Central and Eastern Europe.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Moderna said Tuesday that it has reached an agreement with the U.S. to initially supply 100 million doses of its experimental vaccine for COVID-19, mRNA-1273. The U.S. government has awarded up to $1.525 billion for the vaccine. Las Vegas, Nevada-based Mr. Wok Foods has recalled about 200,000 pounds of meat and poultry products for misbranding and undeclared allergens, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS said. The recalled products may contain known allergens such as milk, wheat, soy, peanuts, or oysters. They may also contain MSG, sesame products, or sulfites. The U.S. Food and Drug Administration approved the first oral drug to treat patients two months of age and older with spinal muscular atrophy (SMA) that can be taken at home. Roche subsidiary Genentech's Evrysdi (risdiplam) is also the second FDA-approved drug to treat this rare and often fatal genetic disease affecting muscle strength and movement.
Follow RTT